First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes

$ 8.00

4.5
(354)
In stock
Description

Results from the SWISS-APERO Trial reported at TCT 2021 and published simultaneously in Circulation

WATCHMAN versus ACP or Amulet devices for left atrial appendage occlusion: a sub-analysis of the multicentre LAARGE registry

WATCHMAN FLX™ Device vs Amplatzer™ Amulet™ Occluder: A Meta-Analysis

Amulet IDE: LAA Occluder Performs Well Against Watchman

Left Atrial Appendage Closure for Stroke Risk Reduction in Nonvalvular Atrial Fibrillation - The Cardiology Advisor

Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device

TCT-93 Left Atrial Appendage Sealing Performance of the Amplatzer Amulet and Watchman FLX Device: A Head-to-Head Comparison

Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device

Acutus Medical Announces FDA Clearance, Commercial Launch of AcQCross Line Extension Compatible with Watchman Delivery System

Current and Future Perspectives on LAAO